Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The Japan topical pain relief market was valued at USD 540.92 Million in 2025, driven by the rising arthritis prevalence in the region. The market is anticipated to grow at a CAGR of 4.90% during the forecast period of 2026-2035, with the values likely to reach USD 872.75 Million by 2035.
Compound Annual Growth Rate
4.9%
Value in USD Million
2026-2035
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Topical pain relief involves the application of creams, gels, or patches directly to the skin to relieve localized pain, offering targeted treatment with minimal systemic effects. It is widely used for conditions such as arthritis, muscle aches, and minor injuries. In Japan, the topical pain relief market is growing steadily, supported by an aging population, rising musculoskeletal conditions, and a strong preference for non-invasive therapies.
Rising Rheumatoid Arthritis Prevalence to Support the Market Expansion
The increasing incidence of rheumatoid arthritis (RA) is significantly driving the growth of the topical pain relief market in Japan. In March 2024, a health report revealed that the estimated prevalence of RA in Japan is approximately 825,000 people, accounting for nearly 0.65% of the population. This rising patient base is expected to boost demand for effective topical therapies, supporting market expansion.
Daiichi Sankyo Healthcare announced the renewal of Patecs Usupita Ship α, an ultra-thin cooling patch indicated for lower-back pain and stiff shoulders. The reformulated topical analgesic was scheduled for launch on June 15, 2026, with the company revising part of the adhesive drug formulation while retaining its ease of application and removal. The Class 3 OTC medicine is positioned for back pain, shoulder stiffness and muscle pain, reinforcing demand for discreet, comfortable topical formats in Japan. The renewal strengthens competition around thin, comfortable and user-friendly patches, encouraging product differentiation through formulation and application characteristics rather than active ingredients alone.
Daiichi Sankyo Healthcare announced Loxonin S Tape mini, its first mini-sized tape within the Loxonin topical range, for launch on April 15, 2026. The patch contains the same concentration of loxoprofen sodium hydrate as the regular Loxonin S Tape but is half its size, allowing more targeted application. The company cited its consumer research showing that around 40% of respondents had cut patches into smaller pieces, highlighting demand for more precise application. The product directly addresses a practical consumer behaviour, cutting conventional patches, thus supporting a shift toward anatomically targeted, ready-to-use topical pain products, thus boosting the growth of the Japan topical pain relief market.
Nippon Chouzai expanded its private-label 5COINS PHARMA OTC portfolio in October 2025 with two topical analgesics, namely Onmaruko, a warming analgesic anti-inflammatory plaster, and Diclofit, a cooling gel-sheet formulation containing diclofenac sodium. Both were priced at ¥550, while Diclofit was designed for once-daily application with 24-hour pain relief. The expansion followed reported 170% year-on-year sales growth for the broader 5COINS PHARMA series during August 2024–July 2025. Expansion of pharmacy private-label topical analgesics could increase price competition while making differentiated warming and cooling formulations more accessible to self-medicating consumers.
Fuji Yakuhin renewed its Suntour LX Tape as Suntour LX Tape α, introducing a four-active-ingredient formulation. Alongside loxoprofen sodium hydrate, the renewed product added glycyrrhetinic acid, l-menthol and tocopherol acetate to target pain and inflammation while providing cooling sensation and supporting blood circulation. The Class 2 OTC topical analgesic is indicated for shoulder and lower-back pain, muscle pain and tendon-sheath inflammation, and is sold through Fuji Yakuhin’s drugstore network. Multi-ingredient reformulation is intensifying product differentiation in Japan’s topical pain segment, allowing brands to compete through combined analgesic, anti-inflammatory, cooling and circulation-supporting benefits.
The Japanese topical pain patch market is evolving towards smaller patches tailored specifically to pain points that cannot be covered by larger patches effectively. In April 2026, Daiichi Sankyo Healthcare introduced Loxonin S Tape mini, which is half the size of its standard Loxonin S Tape. The company’s October 2024 consumer survey found that approximately 40% of respondents cut patches into smaller pieces, particularly for wrists, fingers, necks and other smaller areas. The launch converts this consumer workaround into a dedicated product format, indicating that manufacturers are increasingly designing topical analgesics around precise application rather than one-size-fits-all coverage, thereby boosting the Japan topical pain relief demand.
Wearability and discretion have now become significant features in Japan’s topical pain relief sector. The Daiichi Sankyo Healthcare recently refreshed its Patecs Usupita Ship α in June 2026, with a specific focus on being an ultra-thin cooling patch for pain in the lower back and shoulder rigidity. They kept their focus on making the patch easy to apply and remove by changing the formula of the adhesive used. Its Loxonin EX Tape similarly uses a thinner construction, stretchable material and beige colouring to reduce visibility under clothing. This demonstrates how Japanese manufacturers are competing not only through analgesic efficacy but also through thickness, adhesion, flexibility, removability and everyday wearing comfort.
Topical analgesics from Japan are increasingly integrating active analgesic agents with either warming or cooling effects in order to create unique products, based on the preference of the consumer in terms of their preferred treatment method. One such product is the Loxonin S warming tape from Daiichi Sankyo Healthcare, which integrates both loxoprofen sodium hydrate and nonanoic acid vanillylamide for creating a warming effect, targeting shoulder and lower back pain with stiffness. The company also has traditional cooling topical analgesics.This indicates a move toward multi-dimensional topical formulations, where consumers can select products according to pain location and desired sensory effect rather than choosing solely on the basis of the analgesic ingredient, thus enhancing the growth of Japan topical pain relief market.
Diversification of formulations used for treating topical pain relief is also becoming more common in the Japanese market, including lotions and hard gels in addition to patches and poultices. For example, Nippon Chouzai developed its 5COINS PHARMA Rokionofe L lotion based on loxoprofen sodium hydrate for treating pain in shoulders and low back pain. It has been emphasized by the company that its formulation is light and does not stick to the area where it is applied. Moreover, its use is not restricted by hand usage when applying it on larger areas. Daiichi Sankyo Healthcare has likewise expanded Loxonin into gel and lotion formats. This suggests manufacturers are addressing consumers who want topical treatment without the adhesion, visibility or application constraints associated with patches.
Japan’s topical pain market is seeing greater participation from pharmacy-owned private-label OTC products, creating a lower-priced alternative to established national brands. In October 2025, Nippon Chouzai introduced Onmaruko and Diclofit under its 5COINS PHARMA private-label range, both priced at ¥550. Onmaruko is a warming topical analgesic plaster, while Diclofit is a cooling diclofenac sodium sheet designed to provide effects for 24 hours. Nippon Chouzai stated that sales of its broader 5COINS PHARMA series had reached 170% of the previous year’s level, demonstrating growing traction for pharmacy-led affordable OTC medicines. It shows that competition in Japan's topical pain market is expanding beyond traditional pharmaceutical brands toward pharmacy-owned, price-positioned formulations, potentially increasing affordability and shelf-level competition.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Drug Class
Market Breakup by Formulation
Market Breakup by Packaging Types
Market Breakup by Distribution Channel
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Segmentation Based on Drug Class Holds a High Market Value
Based on the drug class, the market is divided into opioids and non-opioids. Non-opioid topical pain relief products are expected to lead the market, driven by growing concerns over opioid misuse and increasing preference for safer, non-addictive alternatives. These products offer effective pain management with reduced risk, appealing to a broader consumer base.
The Creams and Ointments Segments to Propel Japan Topical Pain Relief Market Growth
The market is segmented into creams and ointments, gels, liquid/oil, patches, sprays, and other formulations. Creams and ointments are expected to dominate the market due to their versatility, ease of application, and effectiveness in delivering localized pain relief. These formulations are preferred for various pain conditions and have a well-established consumer base.
The Tubes Packaging Type Segmentation to Lead the Market
The market, based on the packaging type, is categorized into tubes, containers and jars, aerosol containers, dermal patches, and roll-on bottles. Tubes are anticipated to lead the market, as they are convenient, portable, and easy to use for both consumers and healthcare professionals. Their ability to provide accurate doses and hygienic application enhances their popularity.
Segmentation by Distribution Channel to Shape the Japan Topical Pain Relief Market
Hospital pharmacies, retail pharmacies, online pharmacies, and others together make up the distribution channel. Online pharmacies are expected to lead the market, driven by the growing trend of e-commerce and the convenience of home delivery. This channel is gaining traction due to its accessibility, competitive pricing, and ease of purchasing.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The topical pain relief market in Japan shows regional variation, with the largest demand concentrated in urban areas like Tokyo and Osaka due to higher health awareness and access to healthcare. Rural regions exhibit steady growth, driven by the aging population and increasing preference for convenient, non-invasive pain management. Regional differences highlight varying healthcare accessibility and local preferences for topical treatments.
The key features of the market report comprise patent analysis, grant analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Kobayashi Pharmaceutical Co., Ltd., headquartered in Osaka, Japan, was established in 1886. The company is actively involved in the topical pain relief market with products like Ammeltz, a topical anti-inflammatory pain reliever, and disposable body warmers used for soothing aches and pains. Kobayashi continually innovates to meet the growing demand for localized, non-invasive pain management solutions.
Haleon Group was established in 2019 and is headquartered in Weybridge, United Kingdom. In the topical pain relief market, Haleon is active through leading brands like Voltaren, a widely recognized anti-inflammatory gel. The company’s strong focus on science-based, consumer-trusted products reinforces its growing role in addressing localized pain management needs.
Bayer AG is actively involved in the topical pain relief market. It is headquartered in Leverkusen, Germany, and was established in 1863. Its products, including AleveX topical solutions and Aspirin, address minor arthritis, back, and neck pain. Bayer’s focus on innovative, non-invasive pain relief solutions aligns with Japan's growing demand for effective and accessible topical treatments.
Hisamitsu Pharmaceutical Co., Inc., established in 1847 and headquartered in Tosu, Japan, is a leading player in the Japan topical pain relief market. Its flagship product, Salonpas, a topical analgesic patch, is recognized globally, with a significant market share. Hisamitsu also offers a variety of over-the-counter pain relief products like Nobinobi Salonsip and Air Salonpas, as well as prescription transdermal analgesics, enhancing its presence in both local and international markets.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Johnson & Johnson Services Inc., Pfizer Inc., Sanofi, Reckitt Benckiser Group, Novartis AG, and Taiho Pharma.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Class |
|
| Breakup by Formulation |
|
| Breakup by Packaging Type |
|
| Breakup by Distribution Channel |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.